URINARY-EXCRETION OF 5-S-CYSTEINYLDOPA IN HEALTHY JAPANESE

被引:0
|
作者
MORISHIMA, T
HANAWA, S
机构
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:149 / 150
页数:2
相关论文
共 50 条
  • [41] THE EFFECT OF UVB LIGHT ON SERUM CONCENTRATIONS OF 5-S-CYSTEINYLDOPA
    TEGNER, E
    AGRUP, G
    ROSENGREN, E
    ACTA DERMATO-VENEREOLOGICA, 1983, 63 (02) : 149 - 152
  • [42] EXPERIMENTAL AND CLINICAL INVESTIGATION OF 5-S-CYSTEINYLDOPA IN MALIGNANT-MELANOMA INVIVO - PRODUCTION, EXCRETION AND REGULATORY FACTORS
    ICHIHASHI, M
    MOJAMDAR, M
    MISHIMA, Y
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 1980, 53 (05): : 435 - 435
  • [43] 5-S-CYSTEINYLDOPA, DOPA, AND DOPAMINE IN THE KIDNEY AND SOME OTHER TISSUES
    AGRUP, G
    HANSSON, C
    RORSMAN, H
    ROSENGREN, E
    ACTA DERMATO-VENEREOLOGICA, 1980, 60 (01) : 63 - 64
  • [44] CONJUGATION OF DOPA AND 5-S-CYSTEINYLDOPA WITH CYSTEINE MEDIATED BY SUPEROXIDE RADICAL
    ITO, S
    FUJITA, K
    BIOCHEMICAL PHARMACOLOGY, 1982, 31 (18) : 2887 - 2889
  • [45] Biosynthesis of the pheomelanin precursor 5-S-cysteinyldopa in normal and malignant melanocytes
    Benathan, M
    Labidi, F
    DERMATOLOGY, 1996, 193 (02) : 163 - 163
  • [46] 5-S-cysteinyldopa as diagnostic tumor marker for uveal malignant melanoma
    Goto, H
    Usui, M
    Wakamatsu, K
    Ito, S
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2001, 45 (05) : 538 - 542
  • [47] DISTRIBUTION AND METABOLISM OF TRITIUM-LABELED 5-S-CYSTEINYLDOPA IN MICE
    ITO, S
    TERADAIRA, R
    FUJITA, K
    BIOCHEMICAL PHARMACOLOGY, 1980, 29 (24) : 3277 - 3280
  • [48] FREE AND BOUND 5-S-CYSTEINYLDOPA AND DOPA IN HUMAN MALIGNANT MELANOMAS
    AGRUP, G
    HANSSON, C
    RORSMAN, H
    ROSENGREN, AM
    ROSENGREN, E
    ACTA DERMATO-VENEREOLOGICA, 1978, 58 (03) : 270 - 272
  • [49] Treatment of Primary Melanoma of the Lung Monitored by 5-S-Cysteinyldopa Levels
    Shikuma, Kei
    Omasa, Mitsugu
    Yutaka, Yojiro
    Okuda, Masato
    Taki, Toshihiko
    ANNALS OF THORACIC SURGERY, 2009, 87 (04): : 1264 - 1266
  • [50] Clinical significance of 5-S-cysteinyldopa monitoring in patients with malignant melanoma
    Bánfalvi, T
    Gilde, K
    Boldizsár, M
    Kremmer, T
    NEOPLASMA, 2002, 49 (02) : 121 - 125